 Secondary Objectives: To evaluate i adherence to the medication administration regimen. ii the ability for research staff to collect the required primary and secondary endpoints for the planned full CHAT trial, iii the number of study withdrawals due to administration of open-label statins and withdrawals of consent and iv the impact of the approved consent model on recruitment rates. 